Shell Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Shell Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,965	Closed	-$96K	–	1259
2023 Q2	$96K	Hold	9,965	–	–	﹤0.01%	1129
2023 Q1	$123K	Hold	9,965	–	–	0.01%	1054
2022 Q4	$123K	Hold	9,965	–	–	0.01%	1102
2022 Q3	$122K	Hold	9,965	–	–	﹤0.01%	1155
2022 Q2	$129K	Hold	9,965	–	–	﹤0.01%	1222
2022 Q1	$134K	Hold	9,965	–	–	﹤0.01%	1245
2021 Q4	$132K	Hold	9,965	–	–	﹤0.01%	1294
2021 Q3	$132K	Sell	9,965 -410	-4%	-$6.51K	﹤0.01%	1272
2021 Q2	$135K	Hold	10,375	–	–	﹤0.01%	1313
2021 Q1	$135K	Buy	10,375 +218	+2%	+$3.16K	﹤0.01%	1231
2020 Q4	$140K	Buy	10,157 +8,496	+511%	+$124K	﹤0.01%	1211
2020 Q3	$24K	Buy	1,661 +516	+45%	+$7.47K	﹤0.01%	1365
2020 Q2	$19K	Sell	1,145 -1,655	-59%	-$26.5K	﹤0.01%	1369
2020 Q1	$40K	Hold	2,800	–	–	﹤0.01%	1181
2019 Q4	$57K	Sell	2,800 -2,258	-45%	-$20.8K	﹤0.01%	1204
2019 Q3	$27K	Hold	5,058	–	–	﹤0.01%	1225
2019 Q2	$33K	Sell	5,058 -142	-3%	-$905	﹤0.01%	1207
2019 Q1	$34K	Hold	5,200	–	–	﹤0.01%	1182
2018 Q4	$35K	Hold	5,200	–	–	﹤0.01%	1125
2018 Q3	$34K	Hold	5,200	–	–	﹤0.01%	1148
2018 Q2	$30K	Hold	5,200	–	–	﹤0.01%	1101
2018 Q1	$27K	Buy	5,200 +1,100	+27%	+$5.89K	﹤0.01%	1111
2017 Q4	$19K	Buy	+4,100	New	+$22.8K	﹤0.01%	1106

Other funds holding AUPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Shell Asset Management's AUPH Position: Q3 2023 in Review

Shell Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2023, closing a stake of 9,965 shares — an estimated $96K sold.

Shell Asset Management first reported a position in AUPH in Q4 2017 and held it in 23 quarters. The position peaked at $140K in Q4 2020. 198 funds tracked by Wall St. Rank hold AUPH as of Q3 2023.

Shell Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Shell Asset Management sold 9,965 Aurinia Pharmaceuticals shares in Q3 2023, an estimated $96K.
Shell Asset Management first reported a position in Aurinia Pharmaceuticals in Q4 2017 and held it in 23 quarters.
Shell Asset Management's Aurinia Pharmaceuticals position peaked at $140K in Q4 2020.
198 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2023.

Based on Shell Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.